Cancer Clinical Trial -CSL Behring/Celegene- CSL964_2001
Cancer
Status:
OpenClinicalTrials.gov:
NCT03805789Celgene JCAR017-BCM-003-The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft‑Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant (MODULAATE) not enrolling